Aurobindo Pharma Share Price Target (2026 - 2050)
Aurobindo Pharma Share Price Target 2026 2027 2028 2029 2030 2035 2040 2045 2050 accurate price prediction with target calculator, just enter ur expected cagr and it will show you target
Aurobindo Pharma Share Price Statistic
The Aurobindo Pharma Share Price Statistics section summarizes the stock's key historical performance metrics, including the current share price, daily, weekly, monthly, yearly, and long-term returns. It also highlights the best and worst calendar years, average annual return, maximum drawdown, and the number of positive years. These statistics provide a quick snapshot of Aurobindo Pharma's historical performance and help investors understand its long-term return profile and market volatility.
CURRENT PRICE
1 DAY
1 WEEK
1 MONTH
6 MONTHS
1 YEAR
3 YEARS
5 YEARS
BEST YEAR
WORST YEAR
AVERAGE YEAR
POSITIVE YEARS
Aurobindo Pharma Target and CAGR Calculator
The Aurobindo Pharma Target Calculator helps you to calculate future share price Aurobindo Pharma CAGR Calculator calculates historical annualized returns over different investment periods. Together, these tools help investors compare past performance with future expectations.So you can be realistic about future price.
Aurobindo Pharma Target Price Calculator
The Aurobindo Pharma Target Price Calculator estimates the future share price based on your expected annual return (CAGR) and investment period. Simply choose a target year and expected growth rate to calculate the projected share price, expected return, and total gain. Just enter your Target Year and Expected Returns, and get target instantly.
Target Price
₹0.00
0 years
0%
₹0
Aurobindo Pharma CAGR Calculator
Use the Aurobindo Pharma CAGR Calculator to calculate the compound annual growth rate (CAGR) for any investment period. You can check historical CAGR for the last 1, 2, 3, 5, 10, 15, 20, 25, and 30 years, or select any available period to understand the company's long-term performance. This helps investors compare returns across different investment horizons and evaluate long-term wealth creation.
Just Select no of years you want to check cagr
Aurobindo Pharma Charts
The Aurobindo Pharma Charts provides interactive historical charts, including the price chart, drawdown chart, yearly return chart, and monthly return chart. Analyze long-term trends, compare performance across different periods, identify major corrections, and understand the stock's historical volatility using multiple time ranges from 1 month to the maximum available data.
Scanner & Screeners
Aurobindo Pharma Historical Returns & Price History
Check out Aurobindo Pharma's historical returns and daily price history in one place. The historical returns table shows monthly and yearly percentage returns, It will make you easy to identify strong and weak periods, seasonal trends, and long-term performance. You can check which month Aurobindo Pharma stock is performing well and which it is not. The historical price data table provides daily Open, High, Low, and Close (OHLC) prices, allowing investors to analyze past price movements and compare historical trading activity.
Aurobindo Pharma Performance
The Aurobindo Pharma Historical Returns table displays monthly and yearly returns for each calendar year. It helps you to understand how the stock has performed across different market cycles.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yearly |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Loading... | |||||||||||||
Aurobindo Pharma Price History
The Aurobindo Pharma Historical Price Data table provides daily Open, High, Low, and Close (OHLC) prices. Use the year and month filters to view historical trading data
| Date | Open (₹) | High (₹) | Low (₹) | Close (₹) |
|---|---|---|---|---|
| Loading data... | ||||
Aurobindo Pharma Share Price Target Tomorrow
| Targets | Stoploss | |
|---|---|---|
| 1 | ₹1,716.23 | ₹1,686.53 |
| 2 | ₹1,732.47 | ₹1,673.07 |
| 3 | ₹1,745.93 | ₹1,656.83 |
The 1st target is ₹1,716.23, 2nd target is ₹1,732.47, and 3rd target is ₹1,745.93 for Aurobindo Pharma Tomorrow. For risk management, the 1st stoploss is at ₹1,686.53 and 2nd (wider) stoploss is at ₹1,673.07.
Aurobindo Pharma Share Price Target Next Week
| Targets | Stoploss | |
|---|---|---|
| 1 | ₹1,729.50 | ₹1,679.90 |
| 2 | ₹1,759.00 | ₹1,659.80 |
| 3 | ₹1,779.10 | ₹1,630.30 |
The 1st target is ₹1,729.50, 2nd target is ₹1,759.00, and 3rd target is ₹1,779.10 for Aurobindo Pharma Next Week. For risk management, the 1st stoploss is at ₹1,679.90 and 2nd (wider) stoploss is at ₹1,659.80.
Aurobindo Pharma Share Price Target Next Month
| Targets | Stoploss | |
|---|---|---|
| 1 | ₹1,777.07 | ₹1,596.87 |
| 2 | ₹1,837.13 | ₹1,476.73 |
| 3 | ₹1,957.27 | ₹1,416.67 |
The 1st target is ₹1,777.07, 2nd target is ₹1,837.13, and 3rd target is ₹1,957.27 for Aurobindo Pharma Next Month. For risk management, the 1st stoploss is at ₹1,596.87 and 2nd (wider) stoploss is at ₹1,476.73.
AUROBINDO PHARMA Share Price Target 2026
| CAGR | Target | Stoploss | |
|---|---|---|---|
| 1 | 8% | ₹1,854.36 | ₹1,545.30 |
| 2 | 17% | ₹2,008.89 | ₹1,493.79 |
| 3 | 25% | ₹2,146.25 | ₹1,322.09 |
* Targets calculated based on the latest available price as of 2026-08-31.
The 1st target is ₹1,854.36 (8% CAGR), 2nd target is ₹2,008.89 (17% CAGR), and 3rd target is ₹2,146.25 (25% CAGR) for Aurobindo Pharma in 2026. For risk management, the 1st stoploss is at ₹1,545.30 and 2nd (wider) stoploss is at ₹1,493.79.
AUROBINDO PHARMA Share Price Target 2027
| CAGR | Target | Stoploss | |
|---|---|---|---|
| 1 | 11% | ₹1,887.00 | ₹1,754.91 |
| 2 | 14% | ₹1,938.00 | ₹1,641.69 |
| 3 | 25% | ₹2,125.00 | - |
* Targets are projected using historical CAGR and market assumptions.
The 1st target is ₹1,887.00 (11% CAGR), 2nd target is ₹1,938.00 (14% CAGR), and 3rd target is ₹2,125.00 (25% CAGR) for Aurobindo Pharma in 2027. For risk management, the 1st stoploss is at ₹1,754.91 and 2nd (wider) stoploss is at ₹1,641.69.
AUROBINDO PHARMA Share Price Target 2028
| CAGR | Target | Stoploss | |
|---|---|---|---|
| 1 | 11% | ₹2,094.57 | ₹1,947.95 |
| 2 | 14% | ₹2,209.32 | ₹1,822.28 |
| 3 | 25% | ₹2,656.25 | - |
* Targets are projected using historical CAGR and market assumptions.
The 1st target is ₹2,094.57 (11% CAGR), 2nd target is ₹2,209.32 (14% CAGR), and 3rd target is ₹2,656.25 (25% CAGR) for Aurobindo Pharma in 2028. For risk management, the 1st stoploss is at ₹1,947.95 and 2nd (wider) stoploss is at ₹1,822.28.
AUROBINDO PHARMA Share Price Target 2029
| CAGR | Target | Stoploss | |
|---|---|---|---|
| 1 | 11% | ₹2,324.97 | ₹2,162.22 |
| 2 | 14% | ₹2,518.62 | ₹2,022.73 |
| 3 | 25% | ₹3,320.31 | - |
* Targets are projected using historical CAGR and market assumptions.
The 1st target is ₹2,324.97 (11% CAGR), 2nd target is ₹2,518.62 (14% CAGR), and 3rd target is ₹3,320.31 (25% CAGR) for Aurobindo Pharma in 2029. For risk management, the 1st stoploss is at ₹2,162.22 and 2nd (wider) stoploss is at ₹2,022.73.
AUROBINDO PHARMA Share Price Target 2030
| CAGR | Target | Stoploss | |
|---|---|---|---|
| 1 | 11% | ₹2,580.72 | ₹2,400.07 |
| 2 | 14% | ₹2,871.23 | ₹2,245.23 |
| 3 | 25% | ₹4,150.39 | - |
* Targets are projected using historical CAGR and market assumptions.
The 1st target is ₹2,580.72 (11% CAGR), 2nd target is ₹2,871.23 (14% CAGR), and 3rd target is ₹4,150.39 (25% CAGR) for Aurobindo Pharma in 2030. For risk management, the 1st stoploss is at ₹2,400.07 and 2nd (wider) stoploss is at ₹2,245.23.
AUROBINDO PHARMA Share Price Target 2035
| CAGR | Target | Stoploss | |
|---|---|---|---|
| 1 | 11% | ₹4,348.66 | ₹4,044.26 |
| 2 | 14% | ₹5,528.31 | ₹3,783.34 |
| 3 | 25% | ₹12,665.99 | - |
* Targets are projected using historical CAGR and market assumptions.
The 1st target is ₹4,348.66 (11% CAGR), 2nd target is ₹5,528.31 (14% CAGR), and 3rd target is ₹12,665.99 (25% CAGR) for Aurobindo Pharma in 2035. For risk management, the 1st stoploss is at ₹4,044.26 and 2nd (wider) stoploss is at ₹3,783.34.
AUROBINDO PHARMA Share Price Target 2040
| CAGR | Target | Stoploss | |
|---|---|---|---|
| 1 | 11% | ₹7,327.75 | ₹6,814.81 |
| 2 | 14% | ₹10,644.29 | ₹6,375.14 |
| 3 | 25% | ₹38,653.52 | - |
* Targets are projected using historical CAGR and market assumptions.
The 1st target is ₹7,327.75 (11% CAGR), 2nd target is ₹10,644.29 (14% CAGR), and 3rd target is ₹38,653.52 (25% CAGR) for Aurobindo Pharma in 2040. For risk management, the 1st stoploss is at ₹6,814.81 and 2nd (wider) stoploss is at ₹6,375.14.
AUROBINDO PHARMA Share Price Target 2045
| CAGR | Target | Stoploss | |
|---|---|---|---|
| 1 | 11% | ₹12,347.68 | ₹11,483.35 |
| 2 | 14% | ₹20,494.68 | ₹10,742.49 |
| 3 | 25% | ₹117,961.20 | - |
* Targets are projected using historical CAGR and market assumptions.
The 1st target is ₹12,347.68 (11% CAGR), 2nd target is ₹20,494.68 (14% CAGR), and 3rd target is ₹117,961.20 (25% CAGR) for Aurobindo Pharma in 2045. For risk management, the 1st stoploss is at ₹11,483.35 and 2nd (wider) stoploss is at ₹10,742.49.
AUROBINDO PHARMA Share Price Target 2050
| CAGR | Target | Stoploss | |
|---|---|---|---|
| 1 | 11% | ₹20,806.57 | ₹19,350.11 |
| 2 | 14% | ₹39,460.75 | ₹18,101.71 |
| 3 | 25% | ₹359,989.00 | - |
* Targets are projected using historical CAGR and market assumptions.
The 1st target is ₹20,806.57 (11% CAGR), 2nd target is ₹39,460.75 (14% CAGR), and 3rd target is ₹359,989.00 (25% CAGR) for Aurobindo Pharma in 2050. For risk management, the 1st stoploss is at ₹19,350.11 and 2nd (wider) stoploss is at ₹18,101.71.
Aurobindo Pharma Share Price Prediction 2026 - 2050
Aurobindo Pharma Share Price forecast from 2026 to 2050. Here you will find the target and stoploss levels based on historical performance, CAGR projections, and market analysis. You can also use CAGR calculator to find out target as per your desired CAGR returns.
| Year | T1 (11%) | T2 (14%) | T3 (25%) | SL 1 (7%) | SL 2 (13%) | SL 3 (%) |
|---|---|---|---|---|---|---|
| 2026 | ₹1,853.00 | ₹2,040.00 | ₹2,074.00 | ₹1,615.00 | ₹1,445.00 | - |
| 2027 | ₹1,887.00 | ₹1,938.00 | ₹2,125.00 | ₹1,754.91 | ₹1,641.69 | - |
| 2028 | ₹2,094.57 | ₹2,209.32 | ₹2,656.25 | ₹1,947.95 | ₹1,822.28 | - |
| 2029 | ₹2,324.97 | ₹2,518.62 | ₹3,320.31 | ₹2,162.22 | ₹2,022.73 | - |
| 2030 | ₹2,580.72 | ₹2,871.23 | ₹4,150.39 | ₹2,400.07 | ₹2,245.23 | - |
| 2035 | ₹4,348.66 | ₹5,528.31 | ₹12,665.99 | ₹4,044.26 | ₹3,783.34 | - |
| 2040 | ₹7,327.75 | ₹10,644.29 | ₹38,653.52 | ₹6,814.81 | ₹6,375.14 | - |
| 2045 | ₹12,347.68 | ₹20,494.68 | ₹117,961.20 | ₹11,483.35 | ₹10,742.49 | - |
| 2050 | ₹20,806.57 | ₹39,460.75 | ₹359,989.00 | ₹19,350.11 | ₹18,101.71 | - |
Market Research
Short Term
Bajaj Auto Share Price Target Bajaj Consumer Share Price Target Bajaj Finserv Share Price Target Balaji Amines Share Price Target Balkrishna Industries Share Price Target Divis Lab Share Price Target Dlf Share Price Target Dr Reddys Share Price Target Dreamfolks Share Price Target Dredging Corporation Share Price Target Gppl (Gujarat Pipavav Port) Share Price Target Granules India Share Price Target Graphite India Share Price Target Grasim Share Price TargetAurobindo Pharma Share News Today | Latest News | Price Target Analysis
Aurobindo Pharma Share Price Target 2026 to 2050
About Aurobindo Pharma
Aurobindo Pharma is a leading pharmaceutical company from India. They make medicines that are used worldwide to treat different health conditions.
Their products include antibiotics, heart medicines, and drugs for the nervous system. Even if you don’t see their name on the medicine strip, they supply ingredients to many global pharma brands.
In simple words, Aurobindo Pharma is one of the companies ensuring people across the world get affordable and reliable healthcare.
Top 5 Key Takeaways: Aurobindo Pharma (AUROPHARMA ) Share Price Performance
- Current Valuation: Trading at ₹1,700.00 (Healthcare sector) as of 2026-09-22. Today's movement is -13.40 (-0.78%).
- Short-Term Returns: 1-Day: -0.78% | 1-Week: +2.41% | 1-Month: +4.85%.
- Long-Term Returns: 6-Month: +31.64% | 1-Year: +52.14% | 3-Year: +96.21% | 5-Year: +132.53%.
- Best vs. Worst Year: Peak return in 2023 (+149.31%); lowest return in 2022 (-40.13%).
- Historical Consistency: Average annual return of +27.78% over 8 years, yielding positive returns in 4/8 years.
Frequently asked questions on Aurobindo Pharma Share Price
Yes Aurobindo Pharma is a public sector company, it is partially owned by govt of India.
Aurobindo Pharma is now a 100% Debt free company.
Aurobindo Pharma is a good stock to invest for long term, however you may well keep this in mind that psu stocks some times underperform overall market for several years. if you have patience to hold then only you can invest for long term or invest with a time based or price based stop loss
In covid crash the Aurobindo Pharma share price fell as low as Rs.20 from it all time high
Yes, Aurobindo Pharma stock is highly liquid, which allows to enter and exit quickly.
No. A investor or trader should never invest all his capital in a single share, however he must create a portfolio of stocks
Data sourced from NSE and BSE public records, calculated using adjusted closing prices.
